| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/10/1995 | US5380724 Piperazine and homopiperazine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 01/10/1995 | US5380526 Antidiabetic agent and method of treating diabetes |
| 01/10/1995 | US5380525 Ruminal bacterium for preventing acute lactic acidosis |
| 01/10/1995 | EP0639186A4 Taxol derivatives. |
| 01/05/1995 | WO1995000550A1 Aspb28 insulin crystals |
| 01/05/1995 | WO1995000543A1 Anti-inflammatory peptides |
| 01/05/1995 | WO1995000167A1 Use of human growth hormone for preoperative administration |
| 01/05/1995 | WO1995000161A1 Neuropeptide y antagonists and agonists |
| 01/05/1995 | CA2165200A1 Neuropeptide y antagonists and agonists |
| 01/05/1995 | CA2163453A1 Use of human growth hormone for preoperative administration |
| 01/04/1995 | EP0632036A2 Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| 01/04/1995 | EP0632026A1 Alpha amino acid derivatives, a method for their preparation and pharmaceutical preparations containing them |
| 01/04/1995 | EP0631778A1 Use of L-aspartate or L-asparagine to prevent alcohol toxicity |
| 01/04/1995 | EP0631727A1 Lipase inhibitor derived from a defatted rice germ |
| 01/04/1995 | EP0631616A1 Fatty acid microspheres containing enterococcus for use to enhance growth and improve carcass quality |
| 01/04/1995 | EP0631505A1 Use of a peptide |
| 01/04/1995 | EP0631504A1 Novel medicament |
| 01/04/1995 | EP0631500A1 1 alpha-HYDROXY-24-(EPI)-VITAMIN D4 |
| 01/04/1995 | CN1027264C Process for preparing castano spermine glycosides |
| 01/03/1995 | US5378713 Substituted thienopyrans as antihypertensive agents |
| 01/03/1995 | US5378710 17β-substituted aza-androstane derivatives |
| 01/03/1995 | US5378699 Treatment of immune diseases, cell proliferation, restenosis and smooth muscle cells |
| 01/03/1995 | US5378692 Method of lowering lipids |
| 01/03/1995 | CA2027394C 3-substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis |
| 01/03/1995 | CA1333803C .alpha.-substituted 4-(quinolin-2-yl-methoxy)phenylacetic acids and esters |
| 01/02/1995 | CA2127230A1 Methods and reagents for inhibiting cholesterol absorption in humans mediated by pancreatic cholesterol esterase |
| 12/31/1994 | CA2127068A1 Process for the preparation of native human glicentin |
| 12/31/1994 | CA2127066A1 .alpha.-amino acids derivatives, their preparation process and pharmaceutical compositions containing them |
| 12/31/1994 | CA2126994A1 Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses |
| 12/29/1994 | CA2126709A1 Angiotensin (aii) antagonists as inhibitors of the growth of adipose tissue |
| 12/28/1994 | EP0630383A1 Methods of treating diabetes |
| 12/28/1994 | EP0630379A1 Cyclic ketal derivatives |
| 12/28/1994 | EP0630378A1 Cyclic ketal derivatives |
| 12/28/1994 | EP0630248A1 Use if estriol for treating climacteric osteoporosis |
| 12/28/1994 | EP0630238A1 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa) |
| 12/28/1994 | EP0630181A1 Nutritional product for trauma and surgery patients |
| 12/28/1994 | EP0555351B1 Oxysulfonyl carbamates |
| 12/28/1994 | CN1096787A Sulfur-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism |
| 12/27/1994 | US5376687 For treatment of central nervous system disorders |
| 12/27/1994 | US5376681 Aminocoumaran derivatives, their production and use |
| 12/27/1994 | US5376649 Partial esters of (Di) chloromethanediphosphonic acid useful for treating disorders relating to the metabolism of calcium |
| 12/27/1994 | US5376638 Methods for treating renin-related disorders with amylin antagonists |
| 12/27/1994 | US5376371 Topical; extracts from Salvia and Ginkgo leaves with excipient ; adenylate cyclase agonist and phosphodiesterase inhibitor |
| 12/25/1994 | CA2126400A1 Hypoglycemic agents |
| 12/22/1994 | WO1994029727A1 Inhibiting protein interactions |
| 12/22/1994 | WO1994029290A1 Secondary amines as antidiabetic and antiobesity agents |
| 12/22/1994 | WO1994028895A2 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 12/22/1994 | CA2164009A1 Secondary amines as antidiabetic and antiobesity agents |
| 12/22/1994 | CA2163905A1 Inhibiting protein interactions |
| 12/22/1994 | CA2140660A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 12/21/1994 | EP0629635A1 New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them |
| 12/21/1994 | EP0629405A1 Agent for inhibiting a decrease in bone mass in renal osteodystrophy |
| 12/21/1994 | EP0629199A1 Indole derivatives as 5-ht1 agonists |
| 12/21/1994 | EP0629190A1 Compounds as calcium channel antagonists |
| 12/21/1994 | EP0629184A1 TETRALIN DERIVATIVES AS HMG-CoA REDUCTASE INHIBITORS |
| 12/21/1994 | EP0478787B1 Novel process for producing benzoic acid derivative |
| 12/21/1994 | CN1027068C Alpha-substituted 4-(quinolin-2-yl-methoxy)-phenylacetic acide and-esters |
| 12/21/1994 | CN1027066C Method for manufacturing of novel indole derivative |
| 12/20/1994 | US5374721 Benzo-fused lactams promote release of growth hormone |
| 12/20/1994 | US5374657 Microbial oil mixtures and uses thereof |
| 12/20/1994 | US5374656 N-phenyl-n-alkoxycarbonylalkyl glycinamides, their preparation and the medicaments containing them |
| 12/20/1994 | US5374629 Vitamin D analogues |
| 12/20/1994 | US5374628 Aryl and heteroaryl(phosphinylmethyl)phosphonate squalene synthetase inhibitors and method |
| 12/20/1994 | CA1333647C Heptapeptide analogs of somatostatin |
| 12/18/1994 | CA2126158A1 19-nor steroids phenoxyalkylsulfonamide or phenoxyalkylsulfonylurea chain on 11 beta position, process and intermediates for their preparation, application as medicaments and pharmaceutical compositions containing them |
| 12/14/1994 | EP0627933A1 Bystander suppression of autoimmune diseases |
| 12/14/1994 | EP0543864B1 Novel vitamin d analogues |
| 12/14/1994 | EP0392015B1 Novel derivatives of physiologically active substance ml-236b and process for their preparation |
| 12/14/1994 | EP0101681B1 Antibody to a mediator activity composition and its use in a pharmaceutical composition |
| 12/13/1994 | US5373024 3,5-Substituted benzoylguanidines, process for their preparation, their use as a medicament of diagnostic and medicament containing them |
| 12/13/1994 | US5373023 Antiischaemic agent |
| 12/13/1994 | US5373015 Treating hypertension and congestive heart failure |
| 12/13/1994 | US5373008 Phenylamidine and phenylguanidine derivatives and their use as anti-diabetic agents |
| 12/13/1994 | US5373004 26,28-methylene-1α, 25-dihydroxyvitamin D2 compounds |
| 12/08/1994 | WO1994028153A2 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it |
| 12/08/1994 | WO1994028019A1 Human calcium sensor |
| 12/08/1994 | WO1994028014A2 Peptide inhibitors of urokinase receptor activity |
| 12/08/1994 | WO1994027995A1 New thiazolidindiones and drugs containing them |
| 12/08/1994 | WO1994027623A1 Anti-cholesterolemic egg, vaccine and method for production, and use |
| 12/08/1994 | WO1994027621A1 Iron-binding polymers for oral administration |
| 12/08/1994 | WO1994027620A1 Compositions and process for removing bile salts |
| 12/08/1994 | WO1994027594A2 Stable copper(i) complexes and methods related thereto |
| 12/08/1994 | WO1994027591A1 Therapeutic substituted guanidines |
| 12/08/1994 | WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 12/08/1994 | CA2163741A1 Peptide inhibitors of urokinase receptor activity |
| 12/08/1994 | CA2163737A1 Anti-cholesterolemic egg, vaccine and method for production and use |
| 12/08/1994 | CA2163640A1 Stable copper (i) complexes and their use as active therapeutic substances |
| 12/08/1994 | CA2163013A1 Human calcium sensor |
| 12/07/1994 | EP0627441A1 Crystalline 2-0-alpha-D-glucopyranosyl-L-ascorbic acid, and its preparation and uses |
| 12/07/1994 | EP0627438A1 Methanediphosphonate derivative, process for producing the same, and pharmaceutical use thereof |
| 12/07/1994 | EP0627407A1 (7S)-7-(2(3-chlorophenyl)-2-hydroethylamino-5,6,7,8-tetrahydro-naphthalen-2-yloxy acetic acid, their pharmaceutically acceptable salts with a beta-3-adrenergic agonist activity and pharmaceutical compositions containing them |
| 12/07/1994 | EP0626973A1 Phenylalanine analogs of bombesin |
| 12/07/1994 | EP0626955A1 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
| 12/07/1994 | EP0626952A1 Hypolipidaemic benzothiazepine compounds |
| 12/07/1994 | EP0626940A1 Substituted phenylethenyl compounds having retinoid-like biological activity |
| 12/07/1994 | EP0626851A1 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and dema |
| 12/07/1994 | EP0612211A4 Alteration of rate and character of hair growth. |
| 12/07/1994 | EP0469079B1 Non-absorbable cholesterol esterase inhibitors for decreasing cholesterol absorption |
| 12/06/1994 | US5371103 Thiochroman compounds |
| 12/06/1994 | US5371098 Use of oxazole compounds to treat osteoporosis |